• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

GRAS Notices

  • Print
  • Share
  • E-mail
-

The inventory of GRAS notices provides information about GRAS notices filed since 1998, when FDA received its first GRAS notice. As of October 17, 2016, the GRAS final rule (81 FR 54960; August 17, 2016) requires a specific format for a GRAS notice. Prior to that date, FDA processed GRAS notices under the framework of the GRAS proposed rule (62 FR 18938; April 17, 1997). Notices received prior to the effective date of the GRAS final rule provide examples for potential notifiers for the types of information that may support a GRAS conclusion. In the inventory, notices follow the requirements for the format and content of a GRAS notice as of the effective date of the GRAS final rule.

The inventory notes what type of response letter the FDA sent in response to the notice. Notifiers often resubmit notices that FDA previously ceased to evaluate at the notifier’s request, and resubmitted notices commonly receive a letter indicating FDA has no questions, after addressing deficiencies. In the inventory, entries for notices that were later resubmitted link to the newer entry in the final column. Newer entries for notices that were resubmitted include a link to the previous submission below the substance name.

Some GRNs that FDA previously ceased to evaluate at the notifier’s request were later resubmitted as a food additive petition. For each of these cases, the GRN detail page links to the food additive petition.

After issuing a response letter, we may issue a subsequent letter as circumstances warrant. The issue dates of any subsequent letters are listed under the column, "Date of add’l correspondence.”

As of July 2025, FDA is posting notices in a Docket at www.regulations.gov. In these cases, the link for the notices will take you to the document posted at www.regulations.gov. We will update this information approximately monthly. More information about this inventory is available on the GRAS Notice Inventory Introduction page.


Search and display hints:

  • Select the specific GRN number below to view additional details about any GRAS Notice.
  • To sort by a specific field, click on the column header for that field.
  • To browse the records, use the Show All, First/Previous/Next/Last, and Jump To options at the bottom of the data table.
  • To search for a specific substance/term, enter the term in the Search box and select Show Items to display only those records that contain the selected term. (The search results also includes terms not shown on this page, but included in the full record on the detail page.)
  • The search results will return hits of records containing words that include the search term. For example, a search for the color red will return results that include terms such as reduce, ingredient, and cultured. To limit results to only the searched term, place a space before and after the word in the basic search or in the advanced search “this exact phrase” field.
Download GRAS Notices data in Microsoft Excel web format Download data from this searchable database in Excel format. If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Search within these results
Records Found: 1304 Show All Page 1 of 27
GRN No.
(sorted Z-A)
Substance Date of closure FDA's Letter Date of add'l correspondence Resubmitted as GRN No.
  1304
Preparation containing at least three bacteriophages (phage) specific to Listeria spp. Pending
  1303
Bifidobacterium animalis subsp. lactis CGMCC5470 May 11, 2026 FDA has no questions (in PDF) (240 kB)
  1302
Fermented grape pomace Pending
  1301
Algal oil (≥45% docosahexaenoic acid from Schizochytrium sp. JDW-108) Pending
  1300
Zeaxanthin produced via fermentation using production strain Yarrowia lipolytica CGMCC 39021 May 15, 2026 FDA has no questions (in PDF) (194 kB)
  1299
3′-sialyllactose sodium salt produced via fermentation using production strain Escherichia coli “SLIS109” May 13, 2026 FDA has no questions (in PDF) (299 kB)
  1298
2'-fucosyllactose Pending
  1297
Enzyme-hydrolyzed brown rice protein Pending
  1296
Erythritol produced through fermentation of glucose by Yarrowia lipolytica Pending
  1295
Brazzein preparation produced by Komagataella phaffii GS115 expressing a gene encoding for brazzein from Pentadiplandra brazzeana Pending
  1294
Rebaudioside M produced by enzymatic treatment of steviol glycosides purified from the leaves of Stevia rebaudiana (Bertoni) Bertoni Apr 16, 2026 FDA has no questions (in PDF) (191 kB)
  1293
Brazzein preparation produced by Komagataella phaffii RA-b expressing a gene encoding for brazzein from Pentadiplandra brazzeana Pending
  1292
Citrus-derived compounded sweetener made with neohesperidin dihydrochalcone and gamma cyclodextrin Apr 28, 2026 FDA has no questions (in PDF) (631 kB)
  1291
Wattle (Acacia longifolia) seeds Pending
  1290
Glucose oxidase enzyme preparation produced by Komagataella phaffii expressing a gene encoding glucose oxidase from Aspergillus niger May 6, 2026 FDA has no questions (in PDF) (201 kB)
  1289
Protein-glutamine glutaminase enzyme preparation produced by Bacillus licheniformis expressing a gene encoding protein-glutamine glutaminase from Chryseobacterium viscerum Pending
  1288
Enzyme-modified steviol glycosides Feb 17, 2026 FDA has no questions (in PDF) (220 kB)
  1287
Sucrose oligoesters Mar 23, 2026 FDA has no questions (in PDF) (234 kB)
  1286
Brazzein preparation produced by Zea mays expressing a gene encoding for brazzein from Pentadiplandra brazzeana Pending
  1285
Saccharomyces cerevisiae BY-927 expressing a gene encoding α-acetolactate decarboxylase enzyme from Acetobacter aceti Mar 9, 2026 FDA has no questions (in PDF) (255 kB)
  1284
Recombinant bovine lactoferrin isolate produced by Komagataella phaffii Ppas_337 expressing the gene encoding bovine lactoferrin Mar 25, 2026 FDA has no questions (in PDF) (201 kB)
  1283
Bacillus coagulans BC99 spore preparation Mar 18, 2026 FDA has no questions (in PDF) (256 kB)
  1282
Rebaudioside M produced by enzymatic treatment of rebaudioside A purified from the leaves of Stevia rebaudiana (Bertoni) Bertoni Jan 12, 2026 FDA has no questions (in PDF) (257 kB)
  1281
2'-Fucosyllactose May 8, 2026 Notice does not provide a basis for a GRAS determination (in PDF) (198 kB)
  1280
Pleurotus pulmonarius mycelia and Chlorella vulgaris microalgae Pending
  1279
Saccharomyces cerevisiae CCTCC M2025194 Mar 23, 2026 FDA has no questions (in PDF) (189 kB)
  1278
Lactiplantibacillus plantarum CGMCC 6312 Mar 31, 2026 FDA has no questions (in PDF) (291 kB)
  1277
Autoclaved Parabacteroides goldsteinii RV-01 Jan 22, 2026 At the notifier's request, FDA ceased to evaluate this notice (in PDF) (293 kB)
  1276
Cellulase enzyme preparation produced by Trichoderma reesei expressing a gene encoding a cellulase from Aspergillus niger Apr 8, 2026 FDA has no questions (in PDF) (260 kB)
  1275
6'-Sialyllactose sodium salt Mar 20, 2026 FDA has no questions (in PDF) (277 kB)
  1274
2'-Fucosyllactose Dec 8, 2025 FDA has no questions (in PDF) (353 kB)
  1273
Lacto-N-tetraose Apr 8, 2026 FDA has no questions (in PDF) (295 kB)
  1272
Lacto-N-neotetraose Apr 8, 2026 FDA has no questions (in PDF) (293 kB)
  1271
Short-chain fructooligosaccharides Mar 18, 2026 FDA has no questions (in PDF) (234 kB)
  1270
L-ergothioneine produced by Escherichia coli K-12 MG1655 expressing enzymes from Neurospora crassa and Mycolicibacterium smegmatis MC2 155 Jan 22, 2026 FDA has no questions (in PDF) (230 kB)
  1269
Monellin preparation produced by Komagataella phaffii CBS 150005 expressing a gene encoding for a modified monellin Feb 4, 2026 FDA has no questions (in PDF) (256 kB) Feb 5, 2026
  1268
Mycelial biomass from Rhizomucor pusillus Mar 3, 2026 At the notifier's request, FDA ceased to evaluate this notice (in PDF) (158 kB)
  1267
Sunflower lecithin Feb 17, 2026 FDA has no questions (in PDF) (204 kB)
  1266
Wheat fiber extract from wheat (Triticumaestivum) Feb 17, 2026 FDA has no questions (in PDF) (266 kB)
  1265
Saccharomyces cerevisiae "BY-1532" Dec 11, 2025 FDA has no questions (in PDF) (270 kB)
  1264
Lacticaseibacillus rhamnosus CGMCC18639 Dec 9, 2025 FDA has no questions (in PDF) (268 kB)
  1263
Heyndrickxia coagulans PTA-1273661 spore preparation Dec 9, 2025 FDA has no questions (in PDF) (223 kB)
  1262
2'-Fucosyllactose Apr 8, 2026 FDA has no questions (in PDF) (334 kB)
  1261
2'-Fucosyllactose Jan 26, 2026 FDA has no questions (in PDF) (300 kB)
  1260
Rebaudioside M produced by enzymatic treatment of steviol glycosides purified from the leaves of Stevia rebaudiana (Bertoni) Bertoni Nov 18, 2025 FDA has no questions (in PDF) (261 kB)
  1259
Fungal oil (≥40% arachidonic acid (ARA)) from Mortierella alpina strain TKA-1 Jan 7, 2026 FDA has no questions (in PDF) (198 kB)
  1258
Lacto-N-tetraose Apr 16, 2026 FDA has no questions (in PDF) (296 kB)
  1257
2'-Fucosyllactose Apr 16, 2026 FDA has no questions (in PDF) (326 kB)
  1256
Lemna leaf protein
   (Resubmission of GRN 1160)
Feb 5, 2026 FDA has no questions (in PDF) (260 kB)
  1255
Mycelial biomass of Fusarium compactum CGMCC 41312 (fungal protein) Nov 18, 2025 FDA has no questions (in PDF) (251 kB)

Show All 

jump to page of 27 


GRN No.
(sorted Z-A)
Substance Date of closure FDA's Letter Date of add'l correspondence Resubmitted as GRN No.
-
-